Feasibility and clinical value of CT-guided 125 I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.

MLA

Mo, Zhiqiang, et al. “Feasibility and Clinical Value of CT-Guided 125 I Brachytherapy for Metastatic Soft Tissue Sarcoma after First-Line Chemotherapy Failure.” European Radiology, vol. 28, no. 3, Mar. 2018, pp. 1194–203. EBSCOhost, https://doi.org/10.1007/s00330-017-5036-0.

APA

Mo, Z., Zhang, T., Zhang, Y., Xiang, Z., Yan, H., Zhong, Z., Gao, F., & Zhang, F. (2018). Feasibility and clinical value of CT-guided 125 I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure. European Radiology, 28(3), 1194–1203. https://doi.org/10.1007/s00330-017-5036-0

Chicago

Mo, Zhiqiang, Tao Zhang, Yanling Zhang, Zhanwang Xiang, Huzhen Yan, Zhihui Zhong, Fei Gao, and Fujun Zhang. 2018. “Feasibility and Clinical Value of CT-Guided 125 I Brachytherapy for Metastatic Soft Tissue Sarcoma after First-Line Chemotherapy Failure.” European Radiology 28 (3): 1194–1203. doi:10.1007/s00330-017-5036-0.